Indirect Radiobioassay Information

DOE-STD-1112-98

identification of radionuclides for which the subject was analyzed and other

radionuclides detected

type of measurement--lung, whole body, thyroid, etc.

quantification of the amount of radionuclides (whether positive, negative, or zero)

of each radionuclide measured in each part of the body counted

estimates of counting uncertainty and the total propagated uncertainty (includes

counting and other random and/or systematic uncertainties) at the 1-sigma (1s )

value of the Lc and MDA, in the same units as results, and the expected Type I

and Type II errors

the net count rate and standard error for measurements made for the purposes of

screening only, and not for a quantitative measurement

the value of the customer-specified or service laboratory action level for prompt

notification (this may be documented elsewhere and need not appear in the report)

10.

the signature of the person responsible for the report or his/her designee.

b. Indirect Radiobioassay Information

sample identification

assigned number

total volume or weight of sample submitted

reference dates and times of sample collection and analysis

identification of radionuclides for which the sample was analyzed and other

nuclides detected

quantification of radionuclides using the appropriate blank values, whether

positive, negative, or zero

estimates of counting uncertainty and the total propagated uncertainty (includes

counting, other random, and systematic uncertainties) at one sigma (1 s ) level

identification of specific measurement procedures

value of the Lc and MDA, in the same units as results, and the expected Type I

and Type II errors

10.

the value of the customer-specified or service laboratory action level for prompt

notification (this may be documented in the QA plan and need not appear in the

report)

11.

the signature of the person responsible for the report or his/her designee.